EQT AB shares rise over 7% on news of Qiagen acquisition negotiations
QGEN Qiagen NV
$50.00 +2.25%
View chart & analysis → - 1Qiagen NV shares rose more than 7% on Tuesday.
- 2EQT AB's acquisition offer of over $50 per share valued Qiagen NV at more than $10 billion.
- 3OpenAI acquired Orchestra Bio to enhance drug development artificial intelligence (AI).
So what's the key point?
Qiagen NV shares rose more than 7% after EQT AB made an acquisition proposal. This means the company was valued at more than $10 billion.
Source Investing.com · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.